APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Antiretroviral Agent

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Antiretroviral Agent Industry Growth and Trends Forecast to 2032

Report ID 173966530129 December 2025104 pages

Choose your research edition.

Industry ResearchAntiretroviral Agent Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Antiretroviral Agent Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Antiretroviral Agent Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Antiretroviral Agent Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Antiretroviral Agent Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Antiretroviral Agent market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Antiretroviral Agent is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Antiretroviral Agent include Boehringer Ingelheim, Bristol-Myers Squibb, Genentech, Gilead Sciences, Merck Sharp and Dohme, ViiV Healthcare, AbbVie, GlaxoSmithKline and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Antiretroviral Agent market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Antiretroviral Agent market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Antiretroviral Agent market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Antiretroviral Agent.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Antiretroviral Agent market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Antiretroviral Agent Market by Company

Boehringer Ingelheim

Bristol-Myers Squibb

Genentech

Gilead Sciences

Merck Sharp and Dohme

ViiV Healthcare

AbbVie

GlaxoSmithKline

Pfizer

Mylan

Janssen Pharmaceuticals

Antiretroviral Agent Segment by Type

Fusion Inhibitors

Entry Inhibitors—CCR5 Co-Receptor Antagonist

Nucleoside Reverse Transcriptase Inhibitors

Non-Nucleoside Reverse Transcriptase Inhibitors

Protease Inhibitors

HIV Integrase Strand Transfer Inhibitors

Others

Antiretroviral Agent Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Others

Antiretroviral Agent Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Colombia

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Antiretroviral Agent market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Antiretroviral Agent and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Antiretroviral Agent.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Antiretroviral Agent manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Antiretroviral Agent in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Fusion Inhibitors Table 2. Major Company of Entry Inhibitors—CCR5 Co-Receptor Antagonist Table 3. Major Company of Nucleoside Reverse Transcriptase Inhibitors Table 4. Major Company of Non-Nucleoside Reverse Transcriptase Inhibitors Table 5. Major Company of Protease Inhibitors Table 6. Major Company of HIV Integrase Strand Transfer Inhibitors Table 7. Major Company of Others Table 8. Global Antiretroviral Agent Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 9. Global Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 10. Global Antiretroviral Agent Sales Market Share in Volume by Type (2021-2026) Table 11. Global Antiretroviral Agent Sales by Type (2021-2026) & (US$ Million) Table 12. Global Antiretroviral Agent Sales Market Share in Value by Type (2021-2026) Table 13. Global Antiretroviral Agent Price by Type (2021-2026) & (US$/Unit) Table 14. Global Antiretroviral Agent Sales by Type (2027-2032) & (K Units) Table 15. Global Antiretroviral Agent Sales Market Share in Volume by Type (2027-2032) Table 16. Global Antiretroviral Agent Sales by Type (2027-2032) & (US$ Million) Table 17. Global Antiretroviral Agent Sales Market Share in Value by Type (2027-2032) Table 18. Global Antiretroviral Agent Price by Type (2027-2032) & (US$/Unit) Table 19. North America Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 20. North America Antiretroviral Agent Sales by Type (2021-2026) & (US$ Million) Table 21. Europe Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 22. Europe Antiretroviral Agent Sales by Type (2021-2026) & (US$ Million) Table 23. Asia-Pacific Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 24. Asia-Pacific Antiretroviral Agent Sales by Type (2021-2026) & (US$ Million) Table 25. Latin America Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 26. Latin America Antiretroviral Agent Sales by Type (2021-2026) & (US$ Million) Table 27. Middle East and Africa Antiretroviral Agent Sales by Type (2021-2026) & (K Units) Table 28. Middle East and Africa Antiretroviral Agent Sales by Type (2021-2026) & (US$ Million) Table 29. Antiretroviral Agent Industry Trends Table 30. Antiretroviral Agent Industry Drivers Table 31. Antiretroviral Agent Industry Opportunities and Challenges Table 32. Antiretroviral Agent Industry Restraints Table 33. Global Antiretroviral Agent Sales Revenue by Company (US$ Million) & (2021-2026) Table 34. Global Antiretroviral Agent Revenue Market Share by Company (2021-2026) Table 35. Global Antiretroviral Agent Sales by Company (2021-2026) & (K Units) Table 36. Global Antiretroviral Agent Sales Share by Company (2021-2026) Table 37. Global Antiretroviral Agent Market Price by Company (2021-2026) & (US$/Unit) Table 38. Global Antiretroviral Agent Industry Company Ranking, 2024 VS 2025 VS 2026 Table 39. Global Antiretroviral Agent Major Company Production Sites and Headquarters Table 40. Global Antiretroviral Agent Company, Product Type & Application Table 41. Global Antiretroviral Agent Company Establishment Date Table 42. Global Company Market Concentration Ratio (CR5 and HHI) Table 43. Global Antiretroviral Agent by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 44. Global Antiretroviral Agent Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 45. Global Antiretroviral Agent Sales by Region (2021-2026) & (K Units) Table 46. Global Antiretroviral Agent Sales Market Share in Volume by Region (2021-2026) Table 47. Global Antiretroviral Agent Sales by Region (2021-2026) & (US$ Million) Table 48. Global Antiretroviral Agent Sales Market Share in Value by Region (2021-2026) Table 49. Global Antiretroviral Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 50. Global Antiretroviral Agent Sales by Region (2027-2032) & (K Units) Table 51. Global Antiretroviral Agent Sales Market Share in Volume by Region (2027-2032) Table 52. Global Antiretroviral Agent Sales by Region (2027-2032) & (US$ Million) Table 53. Global Antiretroviral Agent Sales Market Share in Value by Region (2027-2032) Table 54. Global Antiretroviral Agent Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 55. Global Antiretroviral Agent Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 56. Global Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 57. Global Antiretroviral Agent Sales Market Share in Volume by Application (2021-2026) Table 58. Global Antiretroviral Agent Sales by Application (2021-2026) & (US$ Million) Table 59. Global Antiretroviral Agent Sales Market Share in Value by Application (2021-2026) Table 60. Global Antiretroviral Agent Price by Application (2021-2026) & (US$/Unit) Table 61. Global Antiretroviral Agent Sales by Application (2027-2032) & (K Units) Table 62. Global Antiretroviral Agent Sales Market Share in Volume by Application (2027-2032) Table 63. Global Antiretroviral Agent Sales by Application (2027-2032) & (US$ Million) Table 64. Global Antiretroviral Agent Sales Market Share in Value by Application (2027-2032) Table 65. Global Antiretroviral Agent Price by Application (2027-2032) & (US$/Unit) Table 66. North America Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 67. North America Antiretroviral Agent Sales by Application (2021-2026) & (US$ Million) Table 68. Europe Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 69. Europe Antiretroviral Agent Sales by Application (2021-2026) & (US$ Million) Table 70. Asia-Pacific Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 71. Asia-Pacific Antiretroviral Agent Sales by Application (2021-2026) & (US$ Million) Table 72. Latin America Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 73. Latin America Antiretroviral Agent Sales by Application (2021-2026) & (US$ Million) Table 74. Middle East and Africa Antiretroviral Agent Sales by Application (2021-2026) & (K Units) Table 75. Middle East and Africa Antiretroviral Agent Sales by Application (2021-2026) & (US$ Million) Table 76. Boehringer Ingelheim Company Information Table 77. Boehringer Ingelheim Business Overview Table 78. Boehringer Ingelheim Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Boehringer Ingelheim Antiretroviral Agent Product Portfolio Table 80. Boehringer Ingelheim Recent Development Table 81. Bristol-Myers Squibb Company Information Table 82. Bristol-Myers Squibb Business Overview Table 83. Bristol-Myers Squibb Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Bristol-Myers Squibb Antiretroviral Agent Product Portfolio Table 85. Bristol-Myers Squibb Recent Development Table 86. Genentech Company Information Table 87. Genentech Business Overview Table 88. Genentech Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Genentech Antiretroviral Agent Product Portfolio Table 90. Genentech Recent Development Table 91. Gilead Sciences Company Information Table 92. Gilead Sciences Business Overview Table 93. Gilead Sciences Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Gilead Sciences Antiretroviral Agent Product Portfolio Table 95. Gilead Sciences Recent Development Table 96. Merck Sharp and Dohme Company Information Table 97. Merck Sharp and Dohme Business Overview Table 98. Merck Sharp and Dohme Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Merck Sharp and Dohme Antiretroviral Agent Product Portfolio Table 100. Merck Sharp and Dohme Recent Development Table 101. ViiV Healthcare Company Information Table 102. ViiV Healthcare Business Overview Table 103. ViiV Healthcare Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. ViiV Healthcare Antiretroviral Agent Product Portfolio Table 105. ViiV Healthcare Recent Development Table 106. AbbVie Company Information Table 107. AbbVie Business Overview Table 108. AbbVie Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. AbbVie Antiretroviral Agent Product Portfolio Table 110. AbbVie Recent Development Table 111. GlaxoSmithKline Company Information Table 112. GlaxoSmithKline Business Overview Table 113. GlaxoSmithKline Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. GlaxoSmithKline Antiretroviral Agent Product Portfolio Table 115. GlaxoSmithKline Recent Development Table 116. Pfizer Company Information Table 117. Pfizer Business Overview Table 118. Pfizer Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Pfizer Antiretroviral Agent Product Portfolio Table 120. Pfizer Recent Development Table 121. Mylan Company Information Table 122. Mylan Business Overview Table 123. Mylan Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Mylan Antiretroviral Agent Product Portfolio Table 125. Mylan Recent Development Table 126. Janssen Pharmaceuticals Company Information Table 127. Janssen Pharmaceuticals Business Overview Table 128. Janssen Pharmaceuticals Antiretroviral Agent Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Janssen Pharmaceuticals Antiretroviral Agent Product Portfolio Table 130. Janssen Pharmaceuticals Recent Development Table 131. North America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 133. North America Antiretroviral Agent Sales Market Share by Country (2021-2026) Table 134. North America Antiretroviral Agent Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Antiretroviral Agent Sales Market Share Forecast by Country (2027-2032) Table 136. North America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Antiretroviral Agent Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Antiretroviral Agent Market Share by Country (2021-2026) Table 139. North America Antiretroviral Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Antiretroviral Agent Market Share Forecast by Country (2027-2032) Table 141. Europe Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 143. Europe Antiretroviral Agent Sales Market Share by Country (2021-2026) Table 144. Europe Antiretroviral Agent Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Antiretroviral Agent Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Antiretroviral Agent Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Antiretroviral Agent Market Share by Country (2021-2026) Table 149. Europe Antiretroviral Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Antiretroviral Agent Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Antiretroviral Agent Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Antiretroviral Agent Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Antiretroviral Agent Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Antiretroviral Agent Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Antiretroviral Agent Market Share by Country (2021-2026) Table 159. Asia-Pacific Antiretroviral Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Antiretroviral Agent Market Share Forecast by Country (2027-2032) Table 161. Latin America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 163. Latin America Antiretroviral Agent Sales Market Share by Country (2021-2026) Table 164. Latin America Antiretroviral Agent Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Antiretroviral Agent Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Antiretroviral Agent Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Antiretroviral Agent Market Share by Country (2021-2026) Table 169. Latin America Antiretroviral Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Antiretroviral Agent Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Antiretroviral Agent Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Antiretroviral Agent Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Antiretroviral Agent Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Antiretroviral Agent Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Antiretroviral Agent Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Antiretroviral Agent Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Antiretroviral Agent Market Share by Country (2021-2026) Table 179. Middle East and Africa Antiretroviral Agent Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Antiretroviral Agent Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Antiretroviral Agent Distributors List Table 184. Antiretroviral Agent Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Antiretroviral Agent Image Figure 2. Global Antiretroviral Agent Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Antiretroviral Agent Market Size (2021-2032) & (US$ Million) Figure 4. Global Antiretroviral Agent Sales (2021-2032) & (K Units) Figure 5. Fusion Inhibitors Image Figure 6. Global Fusion Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 7. Entry Inhibitors—CCR5 Co-Receptor Antagonist Image Figure 8. Global Entry Inhibitors—CCR5 Co-Receptor Antagonist Sales YoY Growth (2021-2032) & (K Units) Figure 9. Nucleoside Reverse Transcriptase Inhibitors Image Figure 10. Global Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 11. Non-Nucleoside Reverse Transcriptase Inhibitors Image Figure 12. Global Non-Nucleoside Reverse Transcriptase Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 13. Protease Inhibitors Image Figure 14. Global Protease Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 15. HIV Integrase Strand Transfer Inhibitors Image Figure 16. Global HIV Integrase Strand Transfer Inhibitors Sales YoY Growth (2021-2032) & (K Units) Figure 17. Others Image Figure 18. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 19. Global Antiretroviral Agent Market Size Overview by Type (2021-2032) & (US$ Million) Figure 20. Global Antiretroviral Agent Market Share by Type 2025 VS 2032 Figure 21. North America Antiretroviral Agent Sales Market Share in Volume by Type in 2025 Figure 22. North America Antiretroviral Agent Sales Market Share in Value by Type in 2025 Figure 23. Europe Antiretroviral Agent Sales Market Share in Volume by Type in 2025 Figure 24. Europe Antiretroviral Agent Sales Market Share in Value by Type in 2025 Figure 25. Asia-Pacific Antiretroviral Agent Sales Market Share in Volume by Type in 2025 Figure 26. Asia-Pacific Antiretroviral Agent Sales Market Share in Value by Type in 2025 Figure 27. Latin America Antiretroviral Agent Sales Market Share in Volume by Type in 2025 Figure 28. Latin America Antiretroviral Agent Sales Market Share in Value by Type in 2025 Figure 29. Middle East and Africa Antiretroviral Agent Sales Market Share in Volume by Type in 2025 Figure 30. Middle East and Africa Antiretroviral Agent Sales Market Share in Value by Type in 2025 Figure 31. Global Top 5 and 10 Antiretroviral Agent Players Market Share by Revenue in 2025 Figure 32. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Retail Pharmacies Image Figure 34. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 35. Online Pharmacies Image Figure 36. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 37. Hospital Pharmacies Image Figure 38. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 39. Others Image Figure 40. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 41. Global Antiretroviral Agent Market Size Overview by Application (2021-2032) & (US$ Million) Figure 42. Global Antiretroviral Agent Market Share by Application 2025 VS 2032 Figure 43. North America Antiretroviral Agent Sales Market Share in Volume by Application in 2025 Figure 44. North America Antiretroviral Agent Sales Market Share in Value by Application in 2025 Figure 45. Europe Antiretroviral Agent Sales Market Share in Volume by Application in 2025 Figure 46. Europe Antiretroviral Agent Sales Market Share in Value by Application in 2025 Figure 47. Asia-Pacific Antiretroviral Agent Sales Market Share in Volume by Application in 2025 Figure 48. Asia-Pacific Antiretroviral Agent Sales Market Share in Value by Application in 2025 Figure 49. Latin America Antiretroviral Agent Sales Market Share in Volume by Application in 2025 Figure 50. Latin America Antiretroviral Agent Sales Market Share in Value by Application in 2025 Figure 51. Middle East and Africa Antiretroviral Agent Sales Market Share in Volume by Application in 2025 Figure 52. Middle East and Africa Antiretroviral Agent Sales Market Share in Value by Application in 2025 Figure 53. North America Antiretroviral Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. North America Antiretroviral Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. North America Antiretroviral Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. North America Antiretroviral Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Europe Antiretroviral Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Europe Antiretroviral Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Antiretroviral Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Europe Antiretroviral Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Antiretroviral Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 62. Asia-Pacific Antiretroviral Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Antiretroviral Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Asia-Pacific Antiretroviral Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Latin America Antiretroviral Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 66. Latin America Antiretroviral Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 67. Latin America Antiretroviral Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 68. Latin America Antiretroviral Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 69. Middle East and Africa Antiretroviral Agent Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 70. Middle East and Africa Antiretroviral Agent Sales Share by Country: 2021 VS 2025 VS 2032 Figure 71. Middle East and Africa Antiretroviral Agent Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 72. Middle East and Africa Antiretroviral Agent Market Share by Country: 2021 VS 2025 VS 2032 Figure 73. Antiretroviral Agent Value Chain Figure 74. Key Raw Materials Price Figure 75. Manufacturing Cost Structure Figure 76. Antiretroviral Agent Production Mode & Process Figure 77. Direct Comparison with Distribution Share Figure 78. Distributors Profiles Figure 79. Years Considered Figure 80. Research Process Figure 81. Key Executives Interviewed

Scope & coverage.

Types
  • Fusion Inhibitors
  • Entry Inhibitors—CCR5 Co-Receptor Antagonist
  • Nucleoside Reverse Transcriptase Inhibitors
  • Non-Nucleoside Reverse Transcriptase Inhibitors
  • Protease Inhibitors
  • HIV Integrase Strand Transfer Inhibitors
  • Others
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Boehringer Ingelheim
  • Bristol-Myers Squibb
  • Genentech
  • Gilead Sciences
  • Merck Sharp and Dohme
  • ViiV Healthcare
  • AbbVie
  • GlaxoSmithKline
  • Pfizer
  • Mylan
  • Janssen Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Antiretroviral Agent Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Antiretroviral Agent Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Antiretroviral Agent Market by Type
  6. 1.3.1 Fusion Inhibitors
  7. 1.3.2 Entry Inhibitors—CCR5 Co-Receptor Antagonist
  8. 1.3.3 Nucleoside Reverse Transcriptase Inhibitors
  9. 1.3.4 Non-Nucleoside Reverse Transcriptase Inhibitors
  10. 1.3.5 Protease Inhibitors
  11. 1.3.6 HIV Integrase Strand Transfer Inhibitors
  12. 1.3.7 Others
  13. 1.4 Global Antiretroviral Agent Market Size by Type
  14. 1.4.1 Global Antiretroviral Agent Market Size Overview by Type (2021-2032)
  15. 1.4.2 Global Antiretroviral Agent Historic Market Size Review by Type (2021-2026)
  16. 1.4.3 Global Antiretroviral Agent Forecasted Market Size by Type (2027-2032)
  17. 1.5 Key Regions Market Size by Type
  18. 1.5.1 North America Antiretroviral Agent Sales Breakdown by Type (2021-2026)
  19. 1.5.2 Europe Antiretroviral Agent Sales Breakdown by Type (2021-2026)
  20. 1.5.3 Asia-Pacific Antiretroviral Agent Sales Breakdown by Type (2021-2026)
  21. 1.5.4 South America Antiretroviral Agent Sales Breakdown by Type (2021-2026)
  22. 1.5.5 Middle East and Africa Antiretroviral Agent Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Antiretroviral Agent Industry Trends
  2. 2.2 Antiretroviral Agent Industry Drivers
  3. 2.3 Antiretroviral Agent Industry Opportunities and Challenges
  4. 2.4 Antiretroviral Agent Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Antiretroviral Agent Revenue (2021-2026)
  2. 3.2 Global Top Players by Antiretroviral Agent Sales (2021-2026)
  3. 3.3 Global Top Players by Antiretroviral Agent Price (2021-2026)
  4. 3.4 Global Antiretroviral Agent Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Antiretroviral Agent Major Company Production Sites & Headquarters
  6. 3.6 Global Antiretroviral Agent Company, Product Type & Application
  7. 3.7 Global Antiretroviral Agent Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Antiretroviral Agent Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Antiretroviral Agent Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Antiretroviral Agent Tier 1, Tier 2, and Tier 3
4 Antiretroviral Agent Regional Status and Outlook
  1. 4.1 Global Antiretroviral Agent Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Antiretroviral Agent Historic Market Size by Region
  3. 4.2.1 Global Antiretroviral Agent Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Antiretroviral Agent Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Antiretroviral Agent Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Antiretroviral Agent Forecasted Market Size by Region
  7. 4.3.1 Global Antiretroviral Agent Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Antiretroviral Agent Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Antiretroviral Agent Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Antiretroviral Agent by Application
  1. 5.1 Antiretroviral Agent Market by Application
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Antiretroviral Agent Market Size by Application
  7. 5.2.1 Global Antiretroviral Agent Market Size Overview by Application (2021-2032)
  8. 5.2.2 Global Antiretroviral Agent Historic Market Size Review by Application (2021-2026)
  9. 5.2.3 Global Antiretroviral Agent Forecasted Market Size by Application (2027-2032)
  10. 5.3 Key Regions Market Size by Application
  11. 5.3.1 North America Antiretroviral Agent Sales Breakdown by Application (2021-2026)
  12. 5.3.2 Europe Antiretroviral Agent Sales Breakdown by Application (2021-2026)
  13. 5.3.3 Asia-Pacific Antiretroviral Agent Sales Breakdown by Application (2021-2026)
  14. 5.3.4 South America Antiretroviral Agent Sales Breakdown by Application (2021-2026)
  15. 5.3.5 Middle East and Africa Antiretroviral Agent Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Boehringer Ingelheim
  2. 6.1.1 Boehringer Ingelheim Company Information
  3. 6.1.2 Boehringer Ingelheim Business Overview
  4. 6.1.3 Boehringer Ingelheim Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Boehringer Ingelheim Antiretroviral Agent Product Portfolio
  6. 6.1.5 Boehringer Ingelheim Recent Developments
  7. 6.2 Bristol-Myers Squibb
  8. 6.2.1 Bristol-Myers Squibb Company Information
  9. 6.2.2 Bristol-Myers Squibb Business Overview
  10. 6.2.3 Bristol-Myers Squibb Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bristol-Myers Squibb Antiretroviral Agent Product Portfolio
  12. 6.2.5 Bristol-Myers Squibb Recent Developments
  13. 6.3 Genentech
  14. 6.3.1 Genentech Company Information
  15. 6.3.2 Genentech Business Overview
  16. 6.3.3 Genentech Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Genentech Antiretroviral Agent Product Portfolio
  18. 6.3.5 Genentech Recent Developments
  19. 6.4 Gilead Sciences
  20. 6.4.1 Gilead Sciences Company Information
  21. 6.4.2 Gilead Sciences Business Overview
  22. 6.4.3 Gilead Sciences Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Gilead Sciences Antiretroviral Agent Product Portfolio
  24. 6.4.5 Gilead Sciences Recent Developments
  25. 6.5 Merck Sharp and Dohme
  26. 6.5.1 Merck Sharp and Dohme Company Information
  27. 6.5.2 Merck Sharp and Dohme Business Overview
  28. 6.5.3 Merck Sharp and Dohme Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck Sharp and Dohme Antiretroviral Agent Product Portfolio
  30. 6.5.5 Merck Sharp and Dohme Recent Developments
  31. 6.6 ViiV Healthcare
  32. 6.6.1 ViiV Healthcare Company Information
  33. 6.6.2 ViiV Healthcare Business Overview
  34. 6.6.3 ViiV Healthcare Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 ViiV Healthcare Antiretroviral Agent Product Portfolio
  36. 6.6.5 ViiV Healthcare Recent Developments
  37. 6.7 AbbVie
  38. 6.7.1 AbbVie Company Information
  39. 6.7.2 AbbVie Business Overview
  40. 6.7.3 AbbVie Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AbbVie Antiretroviral Agent Product Portfolio
  42. 6.7.5 AbbVie Recent Developments
  43. 6.8 GlaxoSmithKline
  44. 6.8.1 GlaxoSmithKline Company Information
  45. 6.8.2 GlaxoSmithKline Business Overview
  46. 6.8.3 GlaxoSmithKline Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GlaxoSmithKline Antiretroviral Agent Product Portfolio
  48. 6.8.5 GlaxoSmithKline Recent Developments
  49. 6.9 Pfizer
  50. 6.9.1 Pfizer Company Information
  51. 6.9.2 Pfizer Business Overview
  52. 6.9.3 Pfizer Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Pfizer Antiretroviral Agent Product Portfolio
  54. 6.9.5 Pfizer Recent Developments
  55. 6.10 Mylan
  56. 6.10.1 Mylan Company Information
  57. 6.10.2 Mylan Business Overview
  58. 6.10.3 Mylan Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Mylan Antiretroviral Agent Product Portfolio
  60. 6.10.5 Mylan Recent Developments
  61. 6.11 Janssen Pharmaceuticals
  62. 6.11.1 Janssen Pharmaceuticals Company Information
  63. 6.11.2 Janssen Pharmaceuticals Business Overview
  64. 6.11.3 Janssen Pharmaceuticals Antiretroviral Agent Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Janssen Pharmaceuticals Antiretroviral Agent Product Portfolio
  66. 6.11.5 Janssen Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Antiretroviral Agent Sales by Country
  2. 7.1.1 North America Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Antiretroviral Agent Sales by Country (2021-2026)
  4. 7.1.3 North America Antiretroviral Agent Sales Forecast by Country (2027-2032)
  5. 7.2 North America Antiretroviral Agent Market Size by Country
  6. 7.2.1 North America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Antiretroviral Agent Market Size by Country (2021-2026)
  8. 7.2.3 North America Antiretroviral Agent Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Antiretroviral Agent Sales by Country
  2. 8.1.1 Europe Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Antiretroviral Agent Sales by Country (2021-2026)
  4. 8.1.3 Europe Antiretroviral Agent Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Antiretroviral Agent Market Size by Country
  6. 8.2.1 Europe Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Antiretroviral Agent Market Size by Country (2021-2026)
  8. 8.2.3 Europe Antiretroviral Agent Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Antiretroviral Agent Sales by Country
  2. 9.1.1 Asia-Pacific Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Antiretroviral Agent Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Antiretroviral Agent Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Antiretroviral Agent Market Size by Country
  6. 9.2.1 Asia-Pacific Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Antiretroviral Agent Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Antiretroviral Agent Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Antiretroviral Agent Sales by Country
  2. 10.1.1 South America Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Antiretroviral Agent Sales by Country (2021-2026)
  4. 10.1.3 South America Antiretroviral Agent Sales Forecast by Country (2027-2032)
  5. 10.2 South America Antiretroviral Agent Market Size by Country
  6. 10.2.1 South America Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Antiretroviral Agent Market Size by Country (2021-2026)
  8. 10.2.3 South America Antiretroviral Agent Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Antiretroviral Agent Sales by Country
  2. 11.1.1 Middle East and Africa Antiretroviral Agent Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Antiretroviral Agent Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Antiretroviral Agent Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Antiretroviral Agent Market Size by Country
  6. 11.2.1 Middle East and Africa Antiretroviral Agent Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Antiretroviral Agent Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Antiretroviral Agent Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Antiretroviral Agent Value Chain Analysis
  2. 12.1.1 Antiretroviral Agent Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Antiretroviral Agent Production Mode & Process
  7. 12.2 Antiretroviral Agent Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Antiretroviral Agent Distributors
  10. 12.2.3 Antiretroviral Agent Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst